NVIDIA’s last week summarized
Published in Artificial Intelligence.
Bertalan Meskó, MD, PhD
Director of The Medical Futurist Institute (Keynote Speaker, Researcher, Author & Futurist)Director of The Medical Futurist Institute (Keynote Speaker, Researcher, Author & Futurist)
10h • 10h •
NVIDIA’s last week summarized:
– They announced the availability of 25 new cloud-agnostic microservices to help healthcare developers make use of generative AI in their applications.
– Launched about two dozen new AI-powered, healthcare-focused tools at its 2024 GTC AI conference.
– Started a collaboration with with Johnson & Johnson and GE Healthcare for surgery and medical imaging.
And one more field is clinical trials and drug design where they plan to invest even more.
“Last year, NVIDIA invested $50 million in Recursion for its drug discovery projects. Recursion is inputting its biological and chemical data to train NVIDIA’s AI models on its cloud platform. The company has also worked with Roche’s Genentech to develop new medications and better treatment protocols. It also partnered in 2021 with Schrödinger for drug discovery.
One of NVIDIA’s greatest health-care strengths to date is the BioNeMo platform, a generative AI cloud service specifically made for drug development.”
It’s definitely worth keeping an eye on their healthcare efforts!